✦ LIBER ✦

Liver transplantation in the era of model for end-stage liver disease

✍ Scribed by Victor S. Wang; Sammy Saab

Book ID: 111237213
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 122 KB
Volume: 24
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2004.00888.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival after liver transplantation for

Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre–model for end-stage liver disease eras and the independent impact of hepatitis C virus

✍ Paul J. Thuluvath; Anurag Maheshwari; Nimisha P. Thuluvath; Geoffrey C. Nguyen; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

It has been suggested that hepatitis C virus (HCV) patients with hepatocellular carcinoma (HCC) may have worse outcomes after liver transplantation (LT) because of more aggressive tumor biology. In this study, we determined the post-LT survival of HCC patients with and without HCV using United Netwo

Biliary complications following liver tr

Biliary complications following liver transplantation in the model for end-stage liver disease era: Effect of donor, recipient, and technical factors

✍ Theodore H. Welling; David G. Heidt; Michael J. Englesbe; John C. Magee; Randall 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Biliary complications remain a significant problem following liver transplantation in the Model for End-Stage Liver Disease (MELD) era. We hypothesized that donor, recipient, and technical variables may differentially affect anastomotic biliary complications in MELD era liver transplants. We reviewe

Frequency and predictors of de novo hepa

Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era

✍ Carla W. Brady; Alastair D. Smith; Karen M. Stechuchak; Cynthia J. Coffman; Jane 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

In the current system of allocation, patients awaiting orthotopic liver transplantation (OLT) remain at risk of developing de novo hepatocellular carcinoma (HCC) and removal from the waiting list. Using the United Network for Organ Sharing database, we calculated the rate and identified predictors o

Renal outcomes after liver transplantati

Renal outcomes after liver transplantation in the model for end-stage liver disease era

✍ Pratima Sharma; Kathy Welch; Richard Eikstadt; Jorge A. Marrero; Robert J. Fonta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

The proportion of patients undergoing liver transplantation (LT) with renal insufficiency has significantly increased in the Model for End-Stage Liver Disease (MELD) era. This study was designed to determine the incidence and predictors of post-LT chronic renal failure (CRF) and its effect on patien

Liver transplantation cost in the model

Liver transplantation cost in the model for end-stage liver disease era: Looking beyond the transplant admission

✍ Paula Buchanan; Nino Dzebisashvili; Krista L. Lentine; David A. Axelrod; Mark A. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

We examined the relationship between the total cost incurred by liver transplantation (LT) recipients and their Model for End-Stage Liver Disease (MELD) score at the time of transplant. We used a novel database linking billing claims from a large private payer with the Organ Procurement and Transpla

Disparities in liver transplantation in

Disparities in liver transplantation in the post–model for end-stage liver disease era: Are we there yet?

✍ Parul Dureja; Michael R. Lucey 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views